Holdings

Parkman Healthcare Partners LLC

As of Sep 30, 2026, Parkman Healthcare Partners LLC reported 88 positions worth US$1.07B. Largest: PTC Therapeutics, Inc., Eli Lilly and Company and MBX Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
PTC Therapeutics, Inc.700KUS$45.4M+265KSep 30, 2026
Eli Lilly and Company38,119US$44.1M+3,119Sep 30, 2026
MBX Biosciences, Inc.717KUS$42M−83,631Sep 30, 2026
IQVIA Holdings, Inc.145KUS$39M+39,410Sep 30, 2026
DexCom, Inc.437KUS$37.7M−97,733Sep 30, 2026
Inhibrx Biosciences, Inc.360KUS$36.1M+103KSep 30, 2026
Viridian Therapeutics, Inc.1.67MUS$34.5M+297KSep 30, 2026
Scholar Rock Holding Corporation540KUS$26.1MnewSep 30, 2026
CVS Health Corporation286KUS$24.5M−106KSep 30, 2026
Alto Neuroscience, Inc.949KUS$24.2M+520KSep 30, 2026